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Abstract
Background: Aflatoxins are a group of very toxic compounds produced by a fungal species and are found in food products. Aflatoxin
M1 (AFM1) is a type found in dairy products and resistant to pasteurization. AFM1 can adversely affect hepatocytes in human and
leading to various liver diseases. Thus, it is essential to examine raw milk for the presence of AFM1.
Objectives: The current study aimed to evaluate the levels of AFM1 in raw and pasteurized milk produced in Alborz province, Iran.
Materials andMethods: Ninety seven samples of raw milk and 20 samples of pasteurized milk were collected from milk collecting
centers and different supermarkets, respectively. Samples were analyzed to determine AFM1 level by immunoaffinity column chro-
matography, and high-performance liquid chromatography (HPLC) using a C18 column with fluorescence detector. Mobile phase
was water-acetonitrile-methanol (6:2:2 V/V/V) at a flow rate of 1.0 mL/minute.
Results: AFM1 was detected in all samples with various concentration levels ranging from 0.0024 to 0.231µg/kg, the mean concen-
tration = 0.027± 0.018µg/kg.
Conclusions: According to the results of the current study, 9.27% of the raw milk and 5% of the pasteurized milk samples had higher
levels of AFM1 than the maximum recommended limit (0.05µg/kg) by food and agriculture organization (FAO).
Keywords: Aflatoxin M1, High-Performance Liquid Chromatography, Immunoaffinity, Chromatography, Immunoaffinity,
Chromatography, Milk
1. Background
Aflatoxins are mycotoxins produced by Aspergillus
flavus (1). They are toxic substances and have carcinogenic
property for human and animal (2). Aflatoxins are found
in improperly stored chief products such as cassava, chili
peppers, corn, cotton seed, millet, peanuts, rice, sorghum,
sunflower seeds, tree nuts, wheat and a variety of plan-
ets and relative products. The most toxic aflatoxin is afla-
toxin B1 (AFB1) that is easily produced on feed and food
during growth and storage (2-4). Animals are exposed to
these mycotoxins by consumption of feeds contaminated
with mycotoxin-producing molds during growth, harvest
and/or storage. The AFB1 can potentially be converted to
aflatoxin M1 (AFM1) by cytochrome P450 enzyme system in
liver (5). AFM1 is a hydroxylated metabolic form of AFB1
usually excreted in milk through the mammary gland (6).
AFM1 can increase the risk of liver cancer in human (4). It
is also resistant to autoclaving, pasteurization and thermal
inactivation (7). Carcinogenicity of AFB1 is ten times more
than that of AFM1 (8). For this reason, AFB1 was considered
as the primary and AFM1 as the secondary groups for car-
cinogenic compounds by the International Agency for Can-
cer Research (9). Milk and its products are important nutri-
ents for population, but if contaminated with AFM1 or AFB1
they can endanger public health. Therefore, it is quite vital
to determine both the presence and level of these mycotox-
ins in milk and dairy products.
2. Objectives
The present study aimed to evaluate AFM1 levels in 97
samples of raw milk and 20 samples of pasteurized milk
by high-performance liquid chromatography (HPLC).
3. Materials andMethods
3.1. Chemicals, Reagents and Materials
The AFM1 standard was purchased from Supelco (USA);
acetonitrile and methanol were HPLC grade from Merck
(Darmstadt, Germany). All buffers were prepared from
deionized water.
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3.2. Samples
Ninety-seven samples of raw milk and 20 samples of
pasteurized milk were collected from milk collecting cen-
ters and different supermarkets with several brands re-
spectively from January to March 2014.
These samples were transferred to in the Fardis central
laboratory of food and drug. All samples were refrigerated
and analyzed before expiration date.
3.3. Apparatus
The levels of AFM1 were determined by isocratic revers-
phase liquid chromatography using a Shimadzu HPLC sys-
tem (Japan) equipped with a Shimadzu RF-20A florescence
detector, LC-20AD pump, DGU-20A degasser, CTO-20-A sys-
tem controller and LC solution software. The HPLC analy-
sis was performed using C18 column (4.6×250 mm) which
was purchased from Hector RSTCH Corporation. Excitation
and emission wavelengths were selected at 365 and 435
nm, respectively. Immonoaffinity column was prepared
from Libios company (France).
3.4. Determination of AFM1
Milk samples were analyzed for the presence of AFM1
using an immunoaffinity column for cleanup and an HPLC
machine with a florescence detector.
3.5. Sample Preparation
The milk samples (40 mL each) were centrifuged at
3500× g for 10 minutes and upper fat layer was removed.
The remained skim milk was passed through a filter paper
(Whatman No.4). Then, 20 mL of the skimmed milk was
passed through an immunoaffinity column at flow rate of
2 - 3 mL/minute. Column was washed with 20 mL deion-
ized water. Acetonitrile (2.5 mL) was passed through the
column and AFM1 was eluted from it. The eluate was dried
using water bath at 40 - 50°C in a fume hood. Finally, it was
resolved with 1.0 mL of mobile phase. All of the purified
extracts were filtered through a 0.20 µm syringe filter (Jet
Biofilm company) before injection into the HPLC column.
Stock solution of AFM1 was prepared in acetonitrile at
50 ng/mL. Working standard solutions were prepared from
stock standard by diluting with acetonitrile at 0.25 - 1.5
ng/mL. The calibration curve was drawn at concentration
of 0.25, 0.5, 0.75, 1.0, 1.25 and 1.5 ng/mL.
The mobile phase was water-acetonitrile-methanol
(6:2:2 V/V/V) filtered through a 0.45µm membrane and us-
ing flow rate of 1.0 mL/minute.
3.6. Recovery
Recovery percentage was calculated by standard addi-
tion method. A certain amount of standard solution with
specified concentration (50 ng/mL) was added to the con-
trol samples, followed by HPLC analysis according to the
material and method section. The recovery was calculated
by the following formula and reported as percentage.
Recovery percentage =
Obtained amount
Expected amount
× 100%
(1)
4. Results
All 117 samples were analyzed by HPLC technique; 9.27%
of the raw milk and 5% of the pasteurized milk samples
had higher levels of mycotoxins than the maximum rec-
ommended limits by FAO. The retention time under test
condition was at 10.352 ± 0.152 minute (Figures 1 and 2).
The occurrences and levels of AFM1 in raw and pasteurized
milk samples are shown in Table 1.
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Figure 1. The HPLC Chromatogram of 1.0 ng/mL AFM1 Standard Solution
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Figure 2. The HPLC Chromatogram of Milk Sample Containing Aflatoxin M1
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Table 1. The Level of Aflatoxin M1 in Milk
Type ofMilk N Minimum Maximum Mean
Raw 97 0.008 0.231 0.0238± 0.02
Pasteurized 20 0.0024 0.131 0.03± 0.01
5. Discussion
Since milk and dairy products are continuously used as
an important source of healthy diet by human, especially
in infants and children, contamination with AFM1 can be
a great risk to human health. There are many methods
used to detect the AFM1 in milk and dairy products includ-
ing enzyme linked immunosorbent assay (ELISA), radioim-
munoassay, HPLC with fluorescence detection, biosen-
sors, electrokinetics, electrochemical transduction, am-
perometric detection and adsorptive stripping voltamme-
try. Each of these methods has advantages and disadvan-
tages. For example, ELISA has problems such as high back-
ground, coefficient of variation, poor standard curve and
matrix effect. Nonetheless, the HPLC is the most used quan-
titative method in research and routine AFM1 detection.
This technique is very sensitive but requires skilled oper-
ators, extensive pretreatment and expensive equipment.
A few studies have been conducted in Iran and other
countries in this context. Galvano et al. determined the
level of AFM1 in 161 samples of milk, 92 samples of dry milk
and 120 samples of yogurt. The AFM1 was detected in 125
(78%) milk samples (ranging from < 0.001 to 0.0235µg/kg),
49 (53%) dry milk samples (ranging from < 0.001 to 0.0796
µg/kg) and 73 (61%) yogurt samples (ranging from < 0.001
to 0.0321µg/kg). Aflatoxin level in only four samples of dry
milk was more than legal established level by the European
community (EC) in 1999 (10).
In a study conducted by Mohammadi and Alizadeh in
Urmia, Iran, the mean of AFM1 in pasteurized and ultrahigh
treated temperature (UHT) milk samples were 0.023 and
0.019µg/kg, respectively, and the level of AFM1 in milk was
significantly low (11).
Kamkar et al. examined 122 samples for AFM1 and
reported that the mean concentration of AFM1 was 0.04
µg/kg; 14.75% of the samples had higher levels of myco-
toxin (9).
Mohammadi Sani et al. measured AFM1 level in milk
samples in Khorasan, Iran. The AFM1 level found in all sam-
ples had a mean concentration of 0.07792 µg/g. The AFM1
concentrations were lower than those of the Iranian na-
tional standard and food and drug administration (FDA)
limits, but in 80.6% of the samples these levels were higher
than the maximum limit (0.05 µg/kg) accepted by the eu-
ropean union and Codex Alimentarius commission (12).
Shundo and Sabino analyzed 107 samples of raw, pas-
teurized and UHT milk, and AFM1 was detected in 79 (73.8%)
milk samples, ranging from < 0.02 to 0.26µg/kg (13).
Behfar et al. reported AFM1 in100 samples of pasteur-
ized milk in Ahvaz, Iran, with the mean concentration of
0.0027 µg/kg, which was lower than the maximum ac-
cepted level of the country (14).
Mohammadian et al. compared the levels of AFM1 in
raw and pasteurized milk samples during different sea-
sons in Sanandaj, Iran. AFM1 was detected in a wide variety
of concentrations ranging from 0.000007 to 0.115µg/kg in
257 (94.49%) out of 272 milk samples. The AFM1 level in 12
(4.4%) mycotoxin contaminated samples were higher than
the maximum tolerance limit (0.05µg/kg) accepted by Eu-
ropean Union countries (15).
Rahimi et al. examined 121 dairy product samples con-
sisting of pasteurized milk (60 samples) and white cheese
(61 samples), collected from retail markets from August
2010 to September 2011 in Ahvaz, Iran for AFM1. Analytical
results showed that 61 (50.4%) samples were contaminated
with AFM1 ranging from 0.011 to 0.209µg/kg (16).
Vagef and Mahmoudi investigated 144 milk samples
(102 raw and 42 pasteurized milk samples) in west regions
of Iran for AFM1. They found mycotoxin in 43.7% of all sam-
ples with the mean level of 0.0394±0.005µg/kg. The con-
centration of AFM1 in 21.5% of raw cow milk and 11.9% pas-
teurized milk samples were higher than maximum toler-
ance limit accepted by European Union/Codex Alimentar-
ius Commission (0.05µg/kg) (17).
Sefidgar et al. measured AFM1 in raw milk in Babol and
showed that 56.7% of the milk samples were infected to my-
cotoxin at 0.05 - 0.352µg/kg (18).
Pournourmohammadi et al. studied the amount of
AFM1 in pasteurized milk produced in Kerman city using
HPLC with fluorescence detector and demonstrated that
the concentration of contamination was below the Amer-
ican standard limit but in 31 samples (44.7%) the contami-
nation was higher than that of the European limit (19).
Considering toxic effects of AFM1 in human, particu-
larly liver cancer and occurrence of AFM1 in dairy products,
animal feed should be checked for AFB1 and feed storage
should be under appropriate conditions. In addition, milk
and its products should be investigated for AFM1 regularly.
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